Drug Type Autologous CAR-T |
Synonyms BG 2201, BG2201 |
Target |
Action inhibitors |
Mechanism CD7 inhibitors(T-cell antigen CD7 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Myeloid Leukemia | IND Application | China | 01 Aug 2025 | |
| Acute Lymphoblastic Leukemia | IND Application | China | 11 May 2024 |





